Mondelez Lifted Margins, but Cash Flow Fell 81.5%

The headline improvement was a return to year-over-year growth. Revenue reached $10.08B in Q1 FY2026, up 8.3% from $9.31B in Q1 FY2025. Because no consensus forecast or prior management guidance was supplied, the appropriate report-card reference is the same quarter a year earlier. On that basis, revenue cleared the comparison by $0.77B. The supplied materials do not separate this change into volume, pricing, currency or acquisitions, so the source of growth is not disclosed.

Profitability also improved against the depressed year-earlier quarter. Gross profit was $2.80B, equivalent to a 27.8% gross margin. That was 170 basis points above Q1 FY2025’s 26.1%. Operating income was $808M and the operating margin reached 8.0%, up 70 basis points from 7.3%. EPS rose to $0.44 from $0.31, an increase of 41.9%. These figures indicate that some incremental revenue reached the operating and per-share earnings lines, even though profitability remained well below the stronger margins reported before FY2025.

The sequential comparison is less favorable. Revenue declined from $10.50B in Q4 FY2025, gross margin eased from 28.2% to 27.8%, operating margin fell from 9.1% to 8.0%, and EPS declined from $0.52 to $0.44. Seasonality could affect quarter-to-quarter comparisons, but the supplied material does not quantify that effect. The more defensible conclusion is that results improved from the weak Q1 FY2025 base without establishing a clear sequential acceleration.

Cash flow was the major exception. Free cash flow was $0.15B, down from $0.81B in Q1 FY2025. The latest XBRL points show $467M of cash from operations and $312M of capital expenditure, consistent with approximately $155M of free cash flow before rounding. Neither working-capital movements nor other cash-flow drivers were supplied, so the decline cannot be assigned to a specific operational cause. The consolidated figures are documented in the company’s Quarterly Report on Form 10-Q for the period ended June 30, 2026.

The quarter supports the first half of a recovery thesis: Mondelez can expand accounting profit from FY2025’s compressed base. FY2025 gross margin was 28.4%, down sharply from 39.1% in FY2024, while operating margin fell to 9.2% from 17.4%. Q1 FY2026 did not reverse that reset, but the year-over-year improvement in both gross and operating margins shows that the deterioration was not still accelerating against the comparable quarter.

The distinction between recovery and normalization matters. An 8.0% quarterly operating margin remains below every full-year result from FY2016 through FY2025 except none; even FY2016’s full-year margin was 9.9%. The latest result therefore represents improvement from a weak comparison rather than a restoration of historical profitability. A durable thesis would require continued margin progress over several quarters, preferably accompanied by steadier cash conversion.

The cash-flow result keeps the evidence mixed. Revenue rose by $0.77B and net income reached $560M, yet free cash flow was only $0.15B. One quarter of weak cash generation does not establish a structural problem, particularly because quarterly working capital can move substantially. It does, however, prevent the earnings improvement from receiving full credit. The company produced $3.23B of free cash flow in FY2025 and $2.6B over the supplied trailing period, making the latest quarter a soft contribution rather than confirmation of accelerating cash earnings.

Valuation increases the standard of proof. At $62.47, Mondelez has an $80.3B market capitalization, trades at 30.9x TTM EPS of $2.02 and offers a 3.2% TTM free-cash-flow yield. Those figures are not consistent with a market pricing in prolonged impairment. They imply that a considerable portion of the margin and earnings recovery is already expected. The quarter reduced the risk of continued year-over-year deterioration, but it did not demonstrate enough cash conversion to make the shares clearly inexpensive.

There is no prior SageNoodle company record, so this is an initial valuation rather than a revision. We set base-case fair value at $62 per share, approximately equal to the current price. The verdict is Fairly Valued because fair value is 99.2% of the $62.47 market price, comfortably within the 15% band around fair value required for that classification.

The valuation uses normalized EPS multiplied by an explicit earnings multiple. This approach is appropriate to the supplied evidence because historical EPS is available, while EBITDA, detailed segment forecasts and management guidance are not. The assumptions are analytical inputs rather than company guidance. In the base case, normalized EPS reaches $2.50 and receives a 24.8x multiple, producing $62 per share. That EPS assumption is above the current $2.02 TTM figure but below FY2023 and FY2024 EPS of $3.62 and $3.42, respectively. It therefore credits a partial recovery without assuming an immediate return to the pre-FY2025 earnings level.

The bear case is $42 per share, based on $2.00 of normalized EPS and a 21.0x multiple. It describes a business whose margins remain near their reset level and whose cash conversion stays uneven. The bull case is $82 per share, rounded from $3.10 of normalized EPS at 26.5x. That outcome requires several quarters of margin improvement, stronger free cash flow and a return toward the higher earnings levels visible before FY2025.

The quarter justifies recognizing better year-over-year operating momentum, but not increasing fair value beyond $62. Gross and operating margins improved, while free cash flow moved in the opposite direction. A higher valuation would require evidence that the income-statement recovery is durable and cash-backed. EV/EBITDA was not disclosed in the supplied inputs and is therefore not used.

The first risk is that the margin improvement reflects an unusually weak comparison rather than a durable change. Q1 FY2025 gross and operating margins were only 26.1% and 7.3%, respectively. Clearing those levels is encouraging, but the latest 27.8% gross margin and 8.0% operating margin remain far below FY2024’s full-year results. If margins stall near current levels, the $2.50 normalized EPS assumption would be difficult to support.

The second risk is persistent weak cash conversion. Free cash flow fell 81.5% year over year despite higher revenue, operating income and EPS. The supplied materials do not disclose whether working capital, tax timing or another factor caused the decline. If the shortfall reverses, the quarter may prove to be noise. If it continues, accounting earnings would overstate the cash available for debt reduction, dividends, repurchases or reinvestment.

Balance-sheet capacity is another constraint. The latest XBRL points show $20.11B of debt and $1.63B of cash. The supplied data does not provide maturity schedules, interest expense or covenant detail, so refinancing pressure cannot be quantified. Nevertheless, that absolute debt load makes dependable cash generation more important and contributes to the Elevated risk rating.

Finally, the valuation leaves limited protection against execution setbacks. A 30.9x TTM P/E and 3.2% free-cash-flow yield require more than a statistical rebound from a weak quarter. The bull case needs sustained margin recovery and stronger cash flow; the bear case becomes more likely if revenue growth slows before those improvements arrive. The next decisive evidence is not another year-over-year EPS increase by itself, but whether operating progress begins to appear in free cash flow.